Sort
4,870 grants matching “glp 1”
Image-guided Bariatric Arterial Embolization (BAE) for the Treatment of Obesity
$621,857Dara L Kraitchman · Johns Hopkins University · R01 · FY2025 · DK
First-in-human clinical translation of a near-infrared, nerve-specific fluorophore to facilitate tissue-specific fluorescence-guided surgery
$620,782Eric R Henderson · Dartmouth-Hitchcock Clinic · R01 · FY2020 · NS
Engineering commensal bacteria as therapeutic signal mediators
$620,000John C March · Cornell University · DP2 · FY2015 · OD
Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes (T1-DISCO)
$619,880Kristen J Nadeau · University Of Colorado Denver · R01 · FY2023 · HL
Lysosomal Regeneration (LysoGen) and Rescue as a Treatment for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
$619,776Mark W Grinstaff · Boston University (Charles River Campus) · R01 · FY2025 · DK
High-Intensity Ultrasound Ablation for Septal Reduction Therapy of Hypertrophic Cardiomyopathy
$619,280Babak Nazer · University Of Washington · R01 · FY2023 · HL
Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes (T1-DISCO)
$618,131Kristen J Nadeau · University Of Colorado Denver · R01 · FY2022 · HL
Role of intestinal microbiome and gut permeability in the development of Kawasaki Disease vasculitis
$617,730Magali Noval Rivas · Cedars-Sinai Medical Center · R01 · FY2025 · HL
Bactericidal Intravascular Biosensor for Continuous Reading of Lactate in the lCU Ph2
$617,497Hao Chen · Biocrede, Inc. · R44 · FY2019 · GM
A phase I study of RNA-lipid particle vaccines for newly-diagnosed glioblastoma, IND19304 08/21/2020
$617,119Elias Sayour · University Of Florida · R01 · FY2024 · FD
Neural Bases of Cephalic Phase Endocrine Responses
$617,105Alan C Spector · Florida State University · R01 · FY2020 · DK
Role of the GI lymphatic system in hormonal signaling and nutrient metabolism
$616,764Patrick Powing Tso · University Of Cincinnati · R01 · FY2018 · DK
Large animal therapy studies
$616,704William A. Beltran · University Of Pennsylvania · R24 · FY2016 · EY
Neuroprotective And Neurorestorative Signaling Mechanisms
$616,305Mark Mattson · National Institute On Aging · ZIA · FY2009 · AG
DEVELOPING MULTI-ANTIGEN VACCINE FOR THE TREATMENT OF CHRONIC HBV
$615,763Valerian Nakaar · Carogen Corporation · R44 · FY2019 · DK
Optimization of a Combined Drug and Delivery Device for Treatment of Cyanide Poisoning
$615,727Steven E Patterson · University Of Minnesota · U01 · FY2021 · NS
Multi-receptor Targeting of Glioblastoma
$615,701Waldemar Debinski · Wake Forest University Health Sciences · R01 · FY2023 · CA
Diet and the neurodevelopment of impulsivity
$615,411Emily Elizabeth Noble · University Of Georgia · R01 · FY2024 · DK
Treatment of Canine Diabetic Cataracts
$614,547Milton None Wyman · Therapeutic Vision, Inc. · R44 · FY2010 · EY
Neural Mechanisms of Nausea, Vomiting, and Energy Dysregulation
$613,967Bart C De Jonghe · University Of Pennsylvania · R01 · FY2024 · DK
Increased Protein at Breakfast for Weight Management in Overweight Adolescents
$613,588Heather J Leidy · University Of Texas At Austin · R01 · FY2020 · DK
Changes in neural response to eating after bariatric surgery: MRI results
$613,546Thomas A. Wadden · University Of Pennsylvania · R01 · FY2011 · DK
The role of G protein-dependent and -independent EP3 signaling in beta-cell compensation and diabetes
$613,302Michelle E Kimple · University Of Wisconsin-Madison · R01 · FY2025 · DK
Phase 2 Proof-of-Concept Efficacy of BT-11 in Crohn's Disease Patients
$613,188Simon Lichtiger · Landos Biopharma, Inc. · R01 · FY2022 · DK
Prostanoid modulators that reduce brain injury and inflammation after seizures
$613,157Raymond J Dingledine · Emory University · U01 · FY2006 · NS